Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 15,918 | 14,936 | 13,405 | 13,301 | 9,929 |
| Cost of Goods | 7,493 | 7,178 | 6,349 | N/A | N/A |
| Gross Profit | 8,425 | 7,759 | 7,056 | 13,301 | 9,929 |
| Operating Expenses | 5,320 | 4,785 | 4,660 | 0 | 0 |
| Operating Income | 3,598 | 3,152 | 2,746 | 13,301 | 9,929 |
| Interest Expense | 19 | 0 | 0 | 0 | 0 |
| Other Income | 15 | -11 | -49 | 0 | 0 |
| Pre-tax Income | 3,594 | 3,141 | 2,697 | 13,301 | 9,929 |
| Income Tax | 686 | 572 | 510 | N/A | N/A |
| Net Income Continuous | 2,908 | 2,570 | 2,187 | 2,163 | 1,896 |
| Minority Interests | -1 | 2 | -3 | N/A | N/A |
| Net Income | $2,910 | $2,568 | $2,189 | $2,163 | $1,896 |
| EPS Basic Total Ops | 0.11 | 0.10 | 0.10 | 0.12 | 0.10 |
| EPS Basic Continuous Ops | 0.11 | 0.10 | 0.11 | 0.12 | 0.12 |
| EPS Diluted Total Ops | 0.09 | 0.08 | 0.08 | 0.08 | 0.10 |
| EPS Diluted Continuous Ops | 0.09 | 0.08 | 0.08 | 0.08 | 0.12 |
| EBITDA(a) | $3,883 | $3,348 | $2,943 | $13,301 | $9,929 |